Clinical efficacy and safety following dose tapering of ciclosporin in cats with hypersensitivity dermatitis

Journal of Feline Medicine and Surgery
Elizabeth S RobertsStephen King

Abstract

Objectives This study was designed to evaluate the efficacy and safety of reducing ciclosporin (CsA) dosing frequency from daily to every other day (EOD) or twice a week (TW) according to clinical response in cats with hypersensitivity dermatitis (HD) and treated with CsA. Methods One hundred and ninety-one cats with HD were given 7 mg/kg CsA daily for at least 4 weeks. Depending on clinical response, the dosing frequency was tapered from daily to EOD over the next 4 weeks and further to TW for an additional 4 weeks. Safety was evaluated through physical examinations, clinical pathology and the monitoring of adverse events (AEs). Results The majority of cats were able to have their dose of CsA tapered to either EOD (15.5%) or TW (62.9%) according to the clinical response. Observed AEs were most frequently mild and self-limiting vomiting and diarrhea. A higher percentage of AEs occurred with daily administration (73%) compared with other dosing regimens (27%). Conclusions and relevance Following 4 weeks of daily dosing at 7 mg/kg, CsA may be tapered to EOD or TW while maintaining the desired therapeutic response in cats with HD. Additionally, CsA appears to be well tolerated with fewer AEs at EOD or TW dosing. Establishing the l...Continue Reading

References

Jun 25, 2004·Veterinary Dermatology·Robert D LastTrevor J Whitbread
Feb 28, 2006·Australian Veterinary Journal·V R BarrsJ A Beatty
Aug 17, 2006·The Journal of Small Animal Practice·C Noli, F Scarampella
Jun 16, 2009·The Veterinary Clinics of North America. Small Animal Practice·P Jane Armstrong, Geraldine Blanchard
May 7, 2011·Veterinary Dermatology·Nicole A HeinrichMelissa C Eisenschenk
May 2, 2012·Veterinary Research·Yoshikazu TanakaTakashi Sasaki
Nov 28, 2012·The Veterinary Clinics of North America. Small Animal Practice·Brian S Palmeiro
Mar 28, 2013·Veterinary Dermatology·Jean SteffanWolfgang Seewald
Feb 22, 2014·The Proceedings of the Nutrition Society·Emma Foster, Ashley Adamson
Mar 31, 2015·American Journal of Veterinary Research·Michael R LappinElizabeth S Roberts

❮ Previous
Next ❯

Citations

Feb 27, 2018·Journal of Feline Medicine and Surgery·Silvia Colombo, Roberta Sartori
Jan 21, 2021·Veterinary Dermatology·Ralf S MuellerPetra Bizikova

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.